SCHEMBL14933360

SCHEMBL14933360

CC1(C)c2ccccc2-c2cc3c4ccccc4n(-c4ccc(-n5c(=O)c6ccccc6c6ccccc65)cc4)c3cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 1/20 0.35
GLA P06280 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
PGR P06401 5/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14933311 1.00 MAPT (0.38) MAPTLMNAMAPK1KDM4EL3MBTL1
SCHEMBL14933314 1.00 MAPT (0.38) MAPTLMNAMAPK1KDM4EL3MBTL1
SCHEMBL14933387 0.97 MAPT (0.36) MAPTLMNAMAPK1KDM4EL3MBTL1
SCHEMBL14933582 0.97 MAPT (0.36) MAPTLMNAMAPK1KDM4EL3MBTL1
SCHEMBL14933558 0.94 MAPK1 (0.40) MAPTLMNAMAPK1KDM4EL3MBTL1
SCHEMBL14933563 0.94 MAPK1 (0.40) MAPTLMNAMAPK1KDM4EL3MBTL1
SCHEMBL14933316 0.93 PGR (0.36) MAPK1KDM4EL3MBTL1ATMKMT2A
SCHEMBL14822435 0.91 KDM4E (0.43) MAPTMAPK1KDM4EL3MBTL1ATM
SCHEMBL14849805 0.91 KDM4E (0.43) MAPTMAPK1KDM4EL3MBTL1ATM
SCHEMBL802718 0.91 KDM4E (0.43) MAPTMAPK1KDM4EL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 MAPT 1459/4885LMNA 3129/4885MAPK1 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.